Biosplice Therapeutics - Latest News and Information
Technology Pulse
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
Biosplice Therapeutics is a biotechnology company focused on therapeutic modulation of alternative splicing by targeting CLK and DYRK family kinases. The company aims to develop first-in-class therapies that influence tissue-specific RNA splice-site selection to treat disease. Its clinical development programs address osteoarthritis, oncology, neurology, and diabetes, reflecting a focus on diseases driven by splicing dysregulation. Headquartered in the biotech ecosystem, Biosplice advances research into splicing biology to create targeted, disease-modifying treatments.
No recent news for this company.
No recent deals for this company.
